LMRI Lumexa Imaging Holdings, Inc.
$9.44 +7.76%
Healthcare · Services-Medical Laboratories
Lumexa Imaging Holdings, Inc. (LMRI) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $907 million. Shares last traded at $9.44, 51.1% below their 52-week high.
Market Cap
$907M
Shares Out
96.1M
EPS (TTM)
—
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$19.30
52-Week Low
$6.46
Volume
54,699
Avg Vol (3m)
57,750.968
Performance
1W
-0.94%
1M
+35.05%
3M
-25.96%
6M
-47.35%
YTD
-46.24%
1Y
—
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
57.05
SMA (50)
$8.91
SMA (200)
—
Price vs SMA50
+5.96%
Price vs SMA200
—
ATR (14)
$0.75
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $0.02 | 2026-05-12 |
| Q1 2026 | $-0.11 | 2026-05-12 |
Services-Medical Laboratories peers
LMRI vs 14 industry peers (Services-Medical Laboratories), by market cap.
1–14 of 14
| NTRA | Natera, Inc. | $33.1B | -159.23 | 14.37 | -9.0% | +2.17% |
| DGX | Quest Diagnostics | $21.6B | 21.76 | 1.96 | 9.0% | -1.44% |
| LH | Labcorp | $21.0B | 23.93 | 1.50 | 6.3% | -1.40% |
| GH | Guardant Health, Inc. | $17.5B | -41.98 | 17.80 | -42.4% | +2.06% |
| CAI | Caris Life Sciences, Inc. | $5.2B | — | — | — | +3.41% |
| BLLN | Billiontoone, Inc. | $4.8B | — | — | — | +5.38% |
| VCYT | Veracyte, Inc. | $4.3B | 64.47 | 8.28 | 12.8% | +4.50% |
| CELC | Celcuity Inc. | $4.3B | -24.15 | — | — | -0.45% |
| RDNT | Radnet, Inc. | $4.2B | -226.56 | 2.07 | -0.9% | +1.83% |
| GRAL | Grail, Inc. | $2.7B | — | — | — | +7.35% |
| FTRE | Fortrea Holdings Inc. | $1.4B | — | — | — | -0.20% |
| CDNA | Caredx, Inc. | $1.4B | -63.38 | 3.56 | -5.6% | +11.89% |
| PSNL | Personalis, Inc. | $1.1B | -13.55 | — | — | +8.29% |
| LMRI | Lumexa Imaging Holdings, Inc. | $907M | — | — | — | +7.76% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.